Franklin Resources Inc. lessened its stake in shares of Koninklijke Philips (NYSE:PHG – Free Report) by 6.4% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 10,857 shares of the technology company’s stock after selling 739 shares during the quarter. Franklin Resources Inc.’s holdings in Koninklijke Philips were worth $275,000 at the end of the most recent reporting period.
Other large investors have also recently bought and sold shares of the company. O Shaughnessy Asset Management LLC raised its position in shares of Koninklijke Philips by 6.0% during the 4th quarter. O Shaughnessy Asset Management LLC now owns 29,533 shares of the technology company’s stock valued at $748,000 after buying an additional 1,671 shares in the last quarter. Arrowstreet Capital Limited Partnership boosted its position in shares of Koninklijke Philips by 107.9% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 129,624 shares of the technology company’s stock valued at $3,282,000 after purchasing an additional 67,289 shares in the last quarter. Intrust Bank NA grew its holdings in Koninklijke Philips by 41.0% in the fourth quarter. Intrust Bank NA now owns 16,454 shares of the technology company’s stock worth $417,000 after purchasing an additional 4,781 shares during the period. Orion Portfolio Solutions LLC raised its position in shares of Koninklijke Philips by 38.2% in the 4th quarter. Orion Portfolio Solutions LLC now owns 13,497 shares of the technology company’s stock worth $342,000 after purchasing an additional 3,731 shares during the last quarter. Finally, Taikang Asset Management Hong Kong Co Ltd bought a new position in Koninklijke Philips in the 4th quarter valued at approximately $2,532,000. 13.67% of the stock is owned by institutional investors.
Koninklijke Philips Stock Down 0.4 %
NYSE:PHG opened at $23.62 on Friday. The company has a market cap of $22.20 billion, a PE ratio of -28.11, a P/E/G ratio of 0.82 and a beta of 0.81. The company has a current ratio of 1.23, a quick ratio of 0.74 and a debt-to-equity ratio of 0.59. The company’s 50 day moving average is $25.48 and its two-hundred day moving average is $26.71. Koninklijke Philips has a twelve month low of $19.29 and a twelve month high of $32.91.
Koninklijke Philips Cuts Dividend
The firm also recently disclosed an annual dividend, which will be paid on Friday, June 6th. Shareholders of record on Tuesday, May 13th will be paid a dividend of $0.886 per share. This represents a yield of 2.9%. The ex-dividend date of this dividend is Tuesday, May 13th. Koninklijke Philips’s payout ratio is -89.29%.
Analysts Set New Price Targets
Several analysts recently commented on PHG shares. Sanford C. Bernstein raised Koninklijke Philips from a “hold” rating to a “strong-buy” rating in a report on Tuesday, March 18th. StockNews.com upgraded Koninklijke Philips from a “hold” rating to a “buy” rating in a report on Saturday, March 8th. UBS Group upgraded shares of Koninklijke Philips from a “neutral” rating to a “buy” rating in a report on Thursday, February 20th. Finally, BNP Paribas upgraded shares of Koninklijke Philips from a “neutral” rating to an “outperform” rating in a report on Tuesday, February 25th. Two analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy”.
Read Our Latest Analysis on Koninklijke Philips
Koninklijke Philips Company Profile
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Featured Articles
- Five stocks we like better than Koninklijke Philips
- How to Invest in the FAANG Stocks
- 3 Mid-Cap to Mega-Cap Stocks Have Announced Significant Buybacks
- High Flyers: 3 Natural Gas Stocks for March 2022
- These 3 Stocks Have Huge Last 12 Months Shareholder Yields
- The Significance of Brokerage Rankings in Stock Selection
- Prominent Hedge Fund Acquires Huge Stake in HPE: Is It a Buy Now?
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.